Ling Tao, M.D., Ph.D.
Xijing Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ling Tao, M.D., Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:50 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07378163 · Study on the Preferences for PCI Implantation Devices Among Doctors and PatientsXijing Hospital · recruiting · Coronary Artery Disease, Percutaneous Coronary Intervention
- N/ANCT07378137 · Comparing the Components of Composite Endpoints for Healthcare Providers and PatientsXijing Hospital · recruiting · Coronary Artery Disease, Percutaneous Coronary Intervention
- N/ANCT07022587 · Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery LesionsXijing Hospital · recruiting · De Novo Stenosis, Coronary Artery Disease · study chair
- N/ANCT06713876 · Long-term Outcomes of Patients Undergoing ECMO-assisted PCILing Tao, MD, PhD · active not recruiting · Complex High-risk and Indicated Patients
- Ph2NCT06572267 · Safety and Efficacy of Meplazumab in Patients With Coronary Artery DiseaseXijing Hospital · recruiting · Coronary Artery Disease · study chair
- N/ANCT06381271 · Transcatheter Aortic Valve Replacement for Pure Severe Aortic Valve RegurgitationXijing Hospital · recruiting · Aortic Valve Regurgitation
- N/ANCT06379386 · Long-term Prognosis and Valve Durability of TAVRXijing Hospital · recruiting · Aortic Valve Stenosis and Insufficiency
- N/ANCT06373120 · Interventional Ventricular Assist System for PCI in CHIP PatientsShenzhen Core Medical Technology CO.,LTD. · active not recruiting · High-Risk Percutaneous Coronary Intervention (High-risk PCI), Left Ventricular Assist Devices · study chair
- N/ANCT06257043 · Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese PatientsXijing Hospital · recruiting · Aortic Valve Disease Mixed
- N/ANCT06238518 · Intravascular Lithotripsy Versus Conventional Therapy for Severely Calcified Coronary Artery LesionsXijing Hospital · unknown · Severely Calcified Coronary Stenoses, De Novo Stenosis
- N/ANCT05960721 · Low-dose NOAC Versus GDMT After LAAOXijing Hospital · recruiting · Atrial Fibrillation · study chair
- N/ANCT05353140 · LAAO Versus NOAC in Patients with AF and PCIXijing Hospital · recruiting · Atrial Fibrillation, Percutaneous Coronary Intervention · study chair
- N/ANCT05209412 · Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery LesionsXijing Hospital · unknown · De Novo Stenosis, Coronary Artery Disease, Percutaneous Coronary Intervention
- N/ANCT04561739 · Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery LesionsXijing Hospital · active not recruiting · De Novo Stenosis, Coronary Artery Disease · study chair
- N/ANCT01372852 · Plasma Adiponectin Concentration, Activity and Isoforms in Newly Diagnosed and Untreated Type 2 Diabetes MellitusXijing Hospital · unknown · Diabetes Mellitus
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.